• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Pulm Med . Risk factors for severe COVID-19 and development of a predictive model

tetano

Editor, Senior Moderator
BMC Pulm Med


. 2025 Sep 2;25(1):422.
doi: 10.1186/s12890-025-03895-4. Risk factors for severe COVID-19 and development of a predictive model

Ling Zhang[SUP] 1 [/SUP], Xinran Li[SUP] 1 [/SUP], Ziyan Wang[SUP] 1 [/SUP], Lei Zhao[SUP] 2 3 [/SUP], Huixia Gao[SUP] 2 3 [/SUP], Conghui Liu[SUP] 1 [/SUP], Jing Bai[SUP] 1 [/SUP], Tiejun Liu[SUP] 1 [/SUP], Weibin Chen[SUP] 1 [/SUP], Wenqiang Li[SUP] 4 [/SUP], Jingshan Bai[SUP] 5 [/SUP], Aishuang Fu[SUP] 6 [/SUP], Yanlei Ge[SUP] 7 8 9 10 11 [/SUP]



Affiliations
Abstract

A clinical case‒control study was conducted to identify risk factors for severe COVID-19 and to develop a predictive risk model to provide a reference for the dynamic assessment of the severity of disease in COVID-19 patients. A total of 410 patients with COVID-19 were included in the study, of whom 132 had severe or critical cases. The clinical data of the patients were collected, and the variables were subsequently screened via LASSO regression analysis and 10-fold cross-validation. The screened variables were subjected to multifactorial logistic regression analysis to screen out the independent risk factors for patients with severe or critical illnesses, and the independent risk factors were integrated to construct a nomogram. Model performance was evaluated using receiver operating characteristic (ROC) curve analysis, calibration curve analysis, and decision curve analysis (DCA), showing good predictive accuracy. Five variables, including the respiratory rate (R), systolic blood pressure (SBP), plasma albumin (ALB), lactate dehydrogenase (LDH), and C-reactive protein (CRP), were ultimately included to construct a clinical prediction model, with an area under the curve (AUC) of 0.86 (CI 0.82-0.90%). The clinical prediction model constructed in this study using simple clinical indicators can assist in the clinical prediction and identification of patients with heavy or critical COVID-19.

Keywords: COVID-19; Nomogram; Predictive model; SARS-CoV-2.

 
Back
Top